GRCE holders · CITADEL ADVISORS LLC 13F · GRCE stock
CITADEL ADVISORS LLC Grace Therapeutics, Inc. (GRCE) 13F holding
CITADEL ADVISORS LLC reported 98,742 GRCE shares valued at $457.2K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest GRCE 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the GRCE holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 98,742 | $457.2K | COM |
| 2025-12-31 | 42,297 | $147.6K | COM |
| 2025-09-30 | 27,265 | $81.0K | COM |
| 2025-06-30 | 34,382 | $102.1K | COM |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.